Pancreatic ATP-sensitive K+ channels (K ATP ) comprise four inward rectifier subunits 9 (Kir6.2), each associated with a sulphonylurea receptor (SUR1). ATP/ADP binding to Kir6.2 shuts 10 K ATP . Mg-nucleotide binding to SUR1 stimulates K ATP . In the absence of Mg 2+ , SUR1 increases the 11 apparent affinity for nucleotide inhibition at Kir6.2 by an unknown mechanism. We 12 simultaneously measured channel currents and nucleotide binding to Kir6.2. Fits to combined 13 data sets suggest that K ATP closes with only one nucleotide molecule bound. A Kir6.2 mutation 14 (C166S) that increases channel activity did not affect nucleotide binding, but greatly perturbed 15 the ability of bound nucleotide to inhibit K ATP . Mutations at position K205 in SUR1 affected both 16 nucleotide affinity and the ability of bound nucleotide to inhibit K ATP . This suggests a dual role for 17 SUR1 in K ATP inhibition, both in directly contributing to nucleotide binding and in stabilising the 18 nucleotide-bound closed state. 19 20 65 Based on the theoretical FRET efficiency calculated from the Förster equation and available cryo-66 EM structures (Martin et al., 2017, 2019) , we expect 91% FRET efficiency between ANAP at position 67 311 and a TNP-ATP molecule bound to Kir6.2, and only 4% FRET efficiency to TNP-ATP bound to 68 the closest nucleotide-binding site on SUR1 (nucleotide binding site 1, Figure 1D ). We also expect 69 very little FRET between ANAP at position 311 and TNP-ATP bound to neighbouring Kir6.2 subunits 70 74 the codon corresponding to amino acid position 311 (W311 TAG -GFP) and a plasmid encoding an 75 ANAP-specific tRNA/tRNA synthetase pair (pANAP). We also included a dominant negative eukary-76 otic ribosomal release factor (eRF-E55D) in our transfections, which has been shown to increase 77 the amount of full-length, ANAP-labelled protein (Schmied et al., 2014; Puljung et al., 2019). When 78 cultured in the presence of ANAP, full length, fully ANAP-labelled Kir6.2 protein was produced and 79 successfully trafficked to the membrane in the presence of SUR1 (Figure 1-Figure supplement 1; 80 see Materials and Methods). ANAP fluorescence from labelled channels can be separated from 81 unincorporated ANAP or autofluorescence based on emission spectra (Puljung et al., 2019) . How-82 ever, we found it much more convenient to first identify transfected cells or membrane fragments 83 based on the presence of a GFP tag. Thus, we used GFP-tagged Kir6.2 constructs throughout this 84 study, unless otherwise indicated.
Introduction
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ATP-sensitive K+ channels (K ATP ) couple the metabolic state of a cell to its electrical activity (Ashcroft TNP-ATP (red, from PDB accession #5XW6) was docked into the nucleotide-binding site of Kir6.2 and positioned in NBS1 of SUR1 (green, from PDB accession #3AR7) by alignment as described in Materials and Methods. Distances from the native tryptophan at position 311 in Kir6.2 to the fluorescent moieties of the TNP-ATPs are displayed in Å. D. Theoretical FRET efficiency between ANAP and TNP-ATP as a function of distance, calculated from the Förster equation. The distances and corresponding FRET efficiencies between ANAP at position 311 and TNP-ATP bound to Kir6.2 (E Kir ) and SUR1 (E SUR ) are indicated. E. Spectral images acquired from an unroofed membrane expressing Kir6.2*-GFP + SUR1 and exposed to increasing concentrations of TNP-ATP. The y-dimension in each image represents distance. The x-dimension represents wavelength.
F. Line-averaged, background-subtracted spectra from E displayed with increasing concentrations of TNP-ATP coloured from purple to orange.
The three fluorophores have distinct peaks: ANAP at 472 nm, GFP at 508 nm, and TNP-ATP at 561 nm. The shaded rectangle indicates the wavelength range used to measure ANAP intensity. G. Concentration-response relationship for binding of TNP-ATP to Kir6.2*-GFP + SUR1 in unroofed membranes. Data were plotted as / , where is the fluorescence intensity in the absence of nucleotide. The smooth curve is a descriptive Hill fit. 50 = 25.6 µM, ℎ = 0.82, = 0.93, n = 18. H. Concentration-response relationship for binding of TNP-ATP to Kir6.2*-G334D-GFP + SUR1 in unroofed membranes. The dashed blue curve is the fit from G. The orange curve is a descriptive Hill fit to the G334D data. 50 = 493 µM, ℎ = 2.63, = 0.08, n = 9. The inset shows the location of G334D (green) in relation to the inhibitory ATP binding site on Kir6.2 (PDB accession #6BAA). TNP-ATP (PDB accession #5XW6) shown in red sticks. Figure 2C,D) . The apparent 50 for inhibition calculated from Hill fits was an order of 155 magnitude lower than the 50 for binding measured in the same patches ( Figure 2C , Table 2 ). 156 We considered several different gating models to explain this observation. In each model, we as- affinity to the closed state ( , where > 0) and the factor by which nucleotide binding favours 161 channel closure ( , where < 1).
162
Our simultaneous binding and current measurements were well fit with a Monod-Wyman-Changeux 163 (MWC)-type model ( Figure 2D ,E; Monod et al. (1965) ) which has been previously proposed to explain 164 K ATP channel inhibition (Enkvetchakul and Nichols, 2003; Craig et al., 2008; Vedovato et al., 2015) . 165 In our MWC-type model, each ligand binding event ( ) is independent and each bound ligand 166 favours the closed state by the same factor ( for the free parameters of our MWC-type model ( Figure 2F , Table 3 ). Based on these distributions,
172
we estimated = 2.1 × 10 4 M −1 ( = 47.9 µM), = 0.09 ( = 0.08), and = 0.04. The very low 173 value indicates that nucleotide binding was tightly coupled to channel closure; i.e. nucleotides pipette and excised, inside out patch expressing Kir6.2*-GFP + SUR1, with the location of the centre of the spectrometer slit overlaid as a white, vertical line. B. Current (left) and spectra (right) acquired from the same excised, inside-out patch exposed to TNP-ATP and coloured according to concentration. C. Concentration-response (n = 9) for TNP-ATP inhibition of Kir6.2*-GFP + SUR1 currents ( / ) and for quenching of ANAP fluorescence ( / ). Both current inhibition and fluorescence quenching were fit to the Hill equation. Current inhibition: 50 = 6.23 µM, ℎ = 0.92, = 0.96, fluorescence quenching: 50 = 77.7 µM, ℎ = 0.87, = 1.00. D. The same data as in C fit to an MWC-type model. Solid curves represent the median fit; shaded areas represent the 95% quantile interval. Values for the fits are reported in the text and in Table 3 . E. MWC-type model for inhibition of K ATP by nucleotides. Open subunits are shown as circles; closed are shown as squares. Nucleotide-bound subunits are represented by filled symbols. , , and are defined in the text. F. Posterior probability distributions for the MWC-type model generated by MCMC fits to the data in C overlaid on the prior probability distribution (dashed line) for each parameter. have a very strong preference for the closed state of the channel. The low value for also explains 175 why the channels were nearly completely inhibited at TNP-ATP concentrations at which not all the 176 binding sites were occupied, as well as the degree to which channel inhibition is complete at sat-177 urating concentrations of TNP-ATP. Our estimate of was quite low and broadly distributed. We Table 3 ). The Table 3 ). This is a consequence of being so low that even in the MWC- Table 3 . E. Posterior probability distributions for the full MWC-type model fit to
Kir6.2*-C166S-GFP + SUR1 or Kir6.2*-GFP + SUR1 (data from Figure 2F ) overlaid on the prior probability distribution. small change in nucleotide affinity. This is an unexpected finding, as one might expect that an in-204 crease in would allosterically cause a decrease in the apparent affinity for inhibitory nucleotide 205 binding. To resolve this conflict, we again turned to PCF ( Figure 3C ,D). Rundown was much slower 206 for Kir6.2*-C166S-GFP + SUR1, which may reflect the increased of this construct. Measuring 207 current inhibition in combination with nucleotide binding confirmed that whereas the apparent 208 nucleotide affinity was unchanged by the C166S mutation, current inhibition occurred at much 209 higher concentrations compared to binding ( Figure 3D ). How can we explain this paradox? Fits of 210 the data with our MWC-type model ( Figure 3D ,E) suggest that, in addition to the expected effect 211 on , the C166S mutation profoundly affects the ability of bound ligand to close the channel ( ) 212 without affecting ( Figure 3E , Table 3 ). We propose that, in addition to increasing the of the 213 channel, C166 is also important in the transduction pathway from the inhibitory nucleotide binding Figure 4A ). We found only a small increase 222 (approximately 1.5-fold) in apparent 50 compared to the same construct in the presence of SUR1 223 (37.6 µM and 25.6 µM respectively). Unfortunately, we were unable to achieve high enough expres-224 sion of Kir6.2*-GFP alone to carry out PCF experiments in the absence of SUR1. However, we were 225 able to measure currents from unlabelled Kir6.2-GFP alone ( Figure 4B ). As expected Kir6.2-GFP 226 alone was much less sensitive to inhibition by TNP-ATP than Kir6.2-GFP + SUR1.
227
To determine whether SUR1 had complex effects on nucleotide binding that were not revealed of SUR1 was 64.0 µM, higher than the value of 37.6 µM derived from steady-state measurements.
241
We believe this discrepancy arises from the variability in our rate measurements. Nevertheless, 242 the two-fold decrease in for TNP-ATP in the presence of SUR1 suggests that SUR1 stabilises 243 nucleotide binding to Kir6.2. However, these binding measurements do not rule out an indirect, 
allosteric effect of SUR1 on nucleotide binding. To explore the effect of SUR1 more rigorously, we 245 again turned to PCF.
246
As Kir6.2*-GFP expression in the absence of SUR1 was not sufficient for PCF recordings, we 247 took a mutational approach to better understand the role of SUR1 in inhibitory nucleotide binding.
248
SUR1-K205 is located in the L0 linker of SUR1, which connects the first set of transmembrane do-249 mains (TMD0) to the ABC core structure ( Figure 1A , Figure 5A ; Martin et al. (2017) ; Puljung (2018) et al., 2013) . 254 We introduced a charge neutralization (alanine, K205A) and a charge reversal (glutamate, K205E) 255 mutation at this position and measured simultaneous nucleotide binding and current inhibition 256 with PCF ( Figure 5B ,C,D). The binding and inhibition curves for TNP-ATP almost perfectly overlaid 257 for the SUR1-K205A mutant ( Figure 5C ). The same was also true for SUR1-K205E ( Figure 5D ). Data
258
were fit with the MWC-type model as before. Mutating K205 to an alanine or a glutamate resulted 259 in an apparent decrease in nucleotide binding affinity ( Figure 5C ,D,E). This was reflected by a de-260 crease in the estimated for TNP-ATP, which correlated with the degree of conservation of the 261 mutation, i.e. we observed a larger effect for the charge reversal compared to the charge neutral-262 ization mutation ( Figure 5E ). However, in addition to direct effects of K205 on nucleotide binding, 263 we also observed a shift in for both mutations ( Figure 5E ). This suggests a dual role for SUR1 in 264 K ATP inhibition, both in contributing to nucleotide binding and in stabilizing the nucleotide-bound 265 closed state.
266
Discussion
267
We have developed a novel approach that allows for site-specific measurement of nucleotide bind-268 ing to K ATP and concomitant measurements of channel current. Performing these measurements 269 simultaneously allowed us to examine nucleotide regulation of K ATP function in great detail. We which was specific to K ATP . FRET also provided the spatial sensitivity necessary to discriminate 285 between nucleotide binding directly to Kir6.2 and to the nucleotide-binding sites of SUR1. We as-286 sume that any TNP-ATP bound non-specifically to our membranes would be too far from Kir6.2 to 287 cause appreciable FRET. This assumption was confirmed by the lack of FRET between TNP-ATP and 288 a Kir6.2*-GFP mutant (G334D), in which nucleotide binding was severely disrupted ( Figure 1H ).
289
Previous studies have suggested that K ATP inhibition follows an MWC-type model (Trapp et al., 290 , 2003; Drain et al., 2004; Craig et al., 2008; Vedovato et al., 2015) . 291 The majority of this earlier work was performed using single-channel measurements of mutated 292 and/or concatenated channel subunits. In this study, we confirm these results using minimally 293 perturbed channels with nucleotide sensitivity similar to that of wild-type K ATP (Figure 1-Figure   294 supplement 2A). By using an MCMC approach to model fitting, we can also evaluate our models to 295 assess how well the derived parameters were determined by the data. MCMC fits provide a basis 296 for determining credible intervals for our parameter estimates. This allows for direct comparison 297 of values derived from wild-type and different mutant constructs.
1998; Enkvetchakul and Nichols
298
Although we did not explicitly include the effects of PIP 2 on K ATP gating in our model formula-299 tions, we assumed that the effects of PIP 2 on were implicitly modelled in our parameter ; 300 i.e. rundown due to dissociation of PIP 2 manifests as a decrease in rather than a change in the 301 number of channels. Although we were able to extract identifiable parameter estimates for , 302 and , our estimates of for each model we considered were appreciably less well constrained 303 than for the other parameters. We expect that this uncertainty arises from measuring a hetero- in the presence of ATP (Gribble et al., 1998) . This phenomenon may also explain the bell-shaped 369 MgADP concentration-response curve for K ATP , which shows an increase in current at low concen-370 trations, followed by inhibition at higher concentrations (Proks et al., 2010; Vedovato et al., 2015) . 371 Future experiments in which activation and inhibition are measured by PCF for the same ligand 372 will allow us to model the complex response of K ATP under conditions where all three nucleotide 373 binding sites simultaneously affect channel gating (i.e. in the presence of Mg 2+ ).
374
Mutations that cause neonatal diabetes reduce the sensitivity of K ATP to nucleotide inhibition, 375 and reduction in nucleotide sensitivity is broadly correlated with disease severity (McTaggart et al. In contrast to G334D, the C166S mutation does not directly affect nucleotide binding to Kir6.2, 384 but rather disrupts the ability of bound nucleotide to close the channel. This contributes to the 385 decreased nucleotide sensitivity which was previously attributed solely to an increased . In 386 the future, we hope to use this rigorous approach to assess a whole panel of neonatal diabetes 387 mutations in Kir6.2 to better understand the mechanism by which they cause disease.
388
Using PCF allowed us to probe more deeply into the role of SUR1 in regulating nucleotide inhibi-389 tion of K ATP . The cytoplasmic L0 loop of SUR1 was previously implicated in modulation of and 390 nucleotide sensitivity of Kir6.2 (Babenko and Bryan, 2003; Chan et al., 2003; Pratt et al., 2012) . We 391 find that, in addition to directly contributing to tighter nucleotide binding at Kir6.2, SUR1 plays a 392 critical role in preferentially stabilising the closed state of the channel when nucleotides are bound.
393
Whereas a single nucleotide-binding event is sufficient for channel closure when Kir6.2 is associ-394 ated with wild-type SUR1, mutating residue K205 reduced the ability of a single nucleotide to close 395 the channel. This difference manifests in both our MWC-type and single-binding models.
PCF-based approach allows us to probe the interactions between Kir6.2 and SUR1 on two different 398 levels. As we show here, we can use this method to examine the effects of SUR1 on inhibitory 399 nucleotide binding to Kir6.2. We can also adapt this method to study activation of Kir6. 
423
ANAP-tagged Kir6.2 constructs were labelled using amber stop codon suppression as described by 424 Chatterjee et al (Chatterjee et al., 2013) . Transfections were carried out 24 hours after plating (Yan et al., 2007; Lin et al., 2015) . eRF1-E55D was included to increase 433 efficiency of ANAP incorporation (Schmied et al., 2014) . Experiments were carried out 2-4 days 434 after transfection. We also expressed constructs labelled with ANAP at positions I182, F183, F198, 435 and I210. Kir6.2-F183*, Kir6.2-F198*, and Kir6.2-I210* co-expressed with SUR1 did not produce 436 sufficient currents for subsequent experimentation. Mutations at I182 are known to produce pro-437 found effects on nucleotide inhibition of K ATP (Li et al., 2000) . Thus, we did not consider this site 438 for further experimentation. Surface expression assays. 495 We measured surface expression of HA-tagged Kir6.2 subunits using an approach outlined by 496 Zerangue et al. (Zerangue et al., 1999; Puljung et al., 2019) . Cells were plated on 19 mm cov-497 erslips coated with poly-l-lysine and transfected as described above. Following incubation, cells 498 were rinsed with PBS before fixation with 10% formalin for 30 minutes at room temperature. Af-499 ter washing again, cells were blocked with 1% BSA in PBS for 30 minutes at 4 ∘ C before a 1-hour 500 incubation at 4 ∘ C with a 1:1000 dilution (in PBS) of rat anti-HA monoclonal antibodies. Cells were 501 then washed 5 times on ice with 1% BSA in PBS followed by a 30-minute incubation at 4 ∘ C with a as negative controls. In the presence of ANAP, we observed strong trafficking of Kir6.2*-HA-GFP to 512 the plasma membrane, but much less trafficking of Kir6.2*-HA (Figure 1-Figure supplement 1E ).
513
When cells were cultured in the absence of ANAP, we observed little to no Kir6.2 surface expression 514 from cells that were transfected with Kir6.2-W311 TAG -HA or Kir6.2-W311 TAG -HA-GFP, suggesting 515 that prematurely truncated constructs did not traffic to the plasma membrane. In the absence of 516 SUR1, surface expression was weak for both wild-type and tagged constructs, despite the reported 517 ability of Kir6.2-GFP to traffic to the plasma membrane in the absence of SUR1 (John et al., 1998; 518 Makhina and Nichols, 1998). 519 Epifluorescence imaging and spectroscopy. 520 Epifluorescence imaging and spectroscopy were performed using a Nikon Eclipse TE2000-U micro-521 scope with a 60x water immersion objective (Plan Apo VC, NA = 1.2, Nikon; Kingston upon Thames, 522 UK) or a 100x oil immersion objective (Nikon, Apo TIRF, NA = 1.49). Imaging of ANAP was performed 523 using a 385 nm LED source (ThorLabs; Newton, NJ) with a 390/18 nm band-pass excitation filter, an 524 MD416 dichroic and a 479/40 nm band-pass emission filter (all from ThorLabs). GFP was imaged us-525 ing a 490 nm LED source (ThorLabs) with a 480/40 nm band-pass excitation filter, a DM505 dichroic, 526 and a 510 nm long-pass emission filter (all from Chroma; Bellows Falls, VT). Fluorescence spectra 527 were collected by exciting ANAP as above but using a 400 nm long-pass emission filter (ThorLabs), 
then using the fit to correct the intensity of exposures taken during perfusion with test nucleotide 563 solutions.
564
For kinetic measurements, the solution changer and camera were controlled using pClamp 565 10 software coupled to a Digidata 1322A digitizer. Each fragment of unroofed membrane was 566 exposed three times to the same test concentration of nucleotide. Spectra were acquired every 567 three seconds. These technical replicates were averaged and presented as a single experiment.
568
Bleaching was corrected by fitting the ANAP intensity of the last ten spectra acquired during each 569 nucleotide-free solution wash to equation 1.
570
Patch-clamp fluorometry.
571
The tip of the patch pipette was centred on the slit of the spectrometer immediately after patch 572 excision. Currents were measured as described above. Fluorescence emission spectra from the 573 excised patch were acquired concurrently with current measurements, both during test solution 574 application as well as nucleotide-free solution. Background subtraction was slightly imperfect due 575 to the exclusion of TNP-ATP from volume of the glass of the pipette, resulting in spectra that have 576 negative intensities at the TNP-ATP peak at high nucleotide concentrations. However, this over-577 subtraction does not affect the size of the ANAP peak, which we used to quantify nucleotide bind-578 ing.
579
Data processing and presentation.
580
Raw spectrographic images and current traces were pre-processed in Python and Clampfit (Axon) 
The gradient of the linear fit to the observed on-rate ( ) is equivalent to ; is the intercept 594 at zero [ ]. We also measured directly from the dequenching of ANAP following TNP-595 ATP wash-off. As expected, these values were independent of the [ ] applied.
596
Bayesian model fitting.
597
The MWC-type models considered (Figure 2 and 
Two variations on the full MWC model were also considered, and diagrammatic formulations 603 are shown in Figure 2 -Figure supplement 1 Table 3 . Table 3 : Fitted parameters for the MWC-type models. , and their associated quantiles are reported as log 10 values to maintain consistency of the accuracy they are reported at. Pairwise correlation plots of , and from the full MWC-type model fit to Kir6.2*-GFP co-expressed with wild-type SUR1, SUR1-K205A, and SUR1-K205E. B. Pairwise correlation plots of and from the full MWC-type as above with fixed to 0.8 (Trapp et al., 1998) . for the other three constructs). As the two fits were very similar, the dashed curve mostly overlays the solid curve. The most notable differences between the fits are that the negative cooperativity model allows for non-sigmoidal curves, and the single-binding model predicts much larger pedestals of current at saturating concentrations of TNP-ATP than either of the other two models.
